SCHEMBL7934295

SCHEMBL7934295

Cc1ccc(CSc2nnnn2-c2cc(C)ccc2C)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 18/20 0.61
LMNA P02545 7/20 0.58
TSHR P16473 6/20 0.58
HTT P42858 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
USP2 O75604 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
MAPK1 P28482 2/20 0.57
TP53 P04637 2/20 0.57
GAA P10253 1/20 0.57
HKDC1 Q2TB90 1/20 0.57
TDP1 Q9NUW8 1/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53
RAB9A P51151 2/20 0.52
GALR3 O60755 1/20 0.52
ALOX15 P16050 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
RXFP1 Q9HBX9 1/20 0.50
HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7924284 0.92 ALDH1A1 (0.57) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL12225969 0.89 ALDH1A1 (0.54) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL7924136 0.83 ALDH1A1 (0.58) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL17708393 0.81 ALDH1A1 (0.65) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL2538104 0.80 MEN1 (0.58) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL15337542 0.80 ALDH1A1 (0.66) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL1493311 0.79 ALDH1A1 (0.76) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL7924282 0.78 ALDH1A1 (0.48) ALDH1A1LMNATSHRHTTSMN1; SMN2
SCHEMBL13870207 0.75 ALDH1A1 (1.00) ALDH1A1LMNAHTTSMN1; SMN2TP53
SCHEMBL7935217 0.74 ALDH1A1 (0.53) ALDH1A1LMNATSHRHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110257177-A1 BENZYLTHIOTETRAZOLE INHIBITORS OF STORE OPERATED CALCIUM RELEASE CALCIMEDICA, INC. (US) 2011-10-20 US disclosed
US-20110257177-A1 BENZYLTHIOTETRAZOLE INHIBITORS OF STORE OPERATED CALCIUM RELEASE CALCIMEDICA, INC. (US) 2011-10-20 US disclosed
WO-2010034003-A2 BENZYLTHIOTETRAZOLE INHIBITORS OF STORE OPERATED CALCIUM RELEASE CALCIMEDICA, INC. (US) 2010-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257177-A1 BENZYLTHIOTETRAZOLE INHIBITORS OF STORE OPERATED CALCIUM RELEASE SARAF, CACNA1I, ORAI1 ALDH1A1 4357/4885LMNA 1885/4885TSHR 4275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.